Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6785297 | 0.88 | EDNRA (0.66) | EDNRAEDNRB | |
| SCHEMBL7972781 | 0.86 | EDNRA (0.73) | EDNRAEDNRB | |
| SCHEMBL7197091 | 0.85 | EDNRA (0.69) | EDNRAEDNRB | |
| SCHEMBL7849260 | 0.85 | EDNRA (0.62) | EDNRAEDNRB | |
| SCHEMBL6782354 | 0.85 | EDNRA (0.72) | EDNRAEDNRB | |
| SCHEMBL5208403 | 0.84 | EDNRA (0.82) | EDNRAEDNRB | |
| SCHEMBL5496601 | 0.83 | EDNRA (0.68) | EDNRAEDNRB | |
| SCHEMBL7198214 | 0.83 | EDNRA (0.71) | EDNRAEDNRB | |
| SCHEMBL6783690 | 0.83 | EDNRA (0.67) | EDNRAEDNRB | |
| SCHEMBL7198606 | 0.83 | EDNRA (0.66) | EDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6596719-B1 | Manufacturing those compounds, pharmaceutical compositions containing one or more of those compounds as endothelin antagonists, and a method of treating a subject having a disorder involving endothelin with the compounds of the | ACTELIO PHARMACEUTICALS LTD. (CH) | 2003-07-22 | — | — | US | disclosed |
| EP-1137642-A1 | BIS-SULFONAMIDES | Actelion Pharmaceuticals Ltd. (CH) | 2001-10-04 | — | — | EP | disclosed |
| WO-2001017976-A1 | BIS-SULFONAMIDES | ACTELION PHARMACEUTICALS LTD (CH) | 2001-03-15 | — | — | WO | disclosed |